PHARMACY

Innovating, freshening up offerings

BY Antoinette Alexander

With a new president and CEO at the helm, Uniprix is looking to “shake things up a bit.”

(Click here to view the full report.)

On Feb. 2, Philippe Duval officially assumed the role of president and CEO of the Uniprix Group — just the third person to hold that title in the 35 year history of the company — succeeding François Castonguay, who stepped down last August after 20 years.

Having served as president and CEO of the The Société des alcools du Québec (SAQ) until 2013 and as GM of the Society for the Celebration of Montréal’s 375th Anniversary until January of this year, Duval brings to the table a wealth of management and retail experience.

“I came on board on Feb. 2,” he told DSN. “Let’s just say I’m in listening mode, and there’s plenty to learn,” Duval said. “It’s a very competitive market out there right now. No one can afford to run on autopilot because market share doesn’t come easily. That’s why the Uniprix Group has chosen to innovate [and] freshen up our offering and shake things up a bit.”

One development that Duval is especially excited about is its exclusive agreement to bring the Daniele Henkel To Go beauty concept to Uniprix.

The concept launched in February in Kirkland and is now available in 20 locations with more planned in coming months.

A free-standing space featuring a lounge chair invites men and women to relax and enjoy 10- to 30-minute sessions for the face, décolleté or hands.

The Daniele Henkel To Go franchise features the anti-aging LPG Endermolift technology. Certified and trained at the Daniele Henkel Academy, Uniprix beauty consultants service their clientele by evaluating their skin, and prescribing and providing targeted, express anti-aging treatments.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Focusing on member health

BY Michael Johnsen

More and more, Sam’s Club as a brand is becoming associated with health care, and not just through its 604 pharmacy operations, 567 optical locations and 420 hearing facilities. Sam’s Club made headlines in the past year by becoming the first retailer to complement its full suite of healthcare offerings with a health exchange solution created in partnership with health insurer Aetna.

(Click here to view the full report.)

Sam’s Club pharmacies continue to host 10 free monthly health screenings nationwide each year for members and non-members. “Offering free screenings for the fifth consecutive year is part of our commitment to improve the lives and wellbeing of people in the communities we serve,” said Jill Turner-Mitchael, SVP Sam’s Club health and wellness. “We’re determined to continue finding ways to make health care accessible.”

Sam’s Club prides itself on its suite of immunization offerings, which include the ability for small business members to schedule in-office flu vaccinations for their employees at select locations. Such services are communicated to members through Sam’s Club’s bi-monthly wellness magazine, Healthy Living Made Simple, which in its fourth year reaches 8 million members.

“Whenever people visit Sam’s Club at all, I want them to be able to experience health-and-wellness in a way that they leave healthier no matter how they engage with us,” said Sherri Thomas, director, managed care services for Sam’s Club, in discussing the health exchange launch with Drug Store News. “If it’s through our pharmacy, optical or hearing services, if they’re engaged in the exchange, if it’s through our health screenings — I want them to be a healthier person because they’re engaged with Sam’s Club.”

That focus on member health is paying dividends: A J.D. Power 2014 U.S. Pharmacy Study ranked Sam’s Club Pharmacy “Highest in Customer Satisfaction with Mass Merchandiser Pharmacies.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Lawmakers push for transition period to implement AMP-based FULs

BY DSN STAFF

 

ARLINGTON, Va. — Sixty-four members of the U.S. Senate and the House asked Health and Human Services Secretary Sylvia Burwell to adopt at least a one-year transition period for states to implement the April 2015 average manufacturer price based federal upper limits. In a statement, National Association of Chain Drug Stores commended Sens. Johnny Isakson (R-GA) and Mark Warner (D-VA) and Reps. Chris Collins (R-NY) and Rep. Dave Loebsack (D-IA) for leading the way. 
 
According to NACDS, senators urged the Centers for Medicare and Medicare Services to preserve access to important prescription medications for Medicaid patients by supporting “proper and accurate reimbursement for retail community pharmacies that dispense prescription drugs to Medicaid beneficiaries, and ensuring that state Medicaid programs have sufficient time to implement federal regulatory changes.”
 
CMS announced a delay in the implementation of AMP-based FULs last June. Last November, CMS said that at the same time the “Final Rule on Medicaid Covered Outpatient Drugs” is released, it plans to finalize the new FULs and guidance to states for implementing those FULs. In their letter, lawmakers stressed the need for at least a one-year period to help states meet the requirements of the final rule.  
 
“States need time to pass drug reimbursement changes through their legislatures, particularly in light of the fact that a number of state legislatures end their sessions in spring or early summer every year. States will also need sufficient time to conduct cost-of-dispensing studies to allow for the calculation of fair pharmacy reimbursement, as well as time needed to file State Plan Amendments to make adjustments in light of the new FULs,” the House letter stated. 
 
NACDS president and CEO Steven Anderson expressed his appreciation to the lawmakers in signing the letters: “The implementation of these AMP-based FULs poses great concern for pharmacy patient care. And we appreciate the recognition by U.S. Senators and Representatives of the need for an adequate transition period so that states have an opportunity to make an effective transition to help preserve access to pharmacy services for low-income Americans.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?